AFP and hepatocellular carcinoma: Alpha-fetoproteins combined with ultrasound scans are the current tools used to screen for hepatocellular carcinoma, and 30−50% of patients do not express alpha-fetoprotein; therefore, there is a need for a new detection method [22].